T cells from AD patients and AD mouse models are hyperactive to Aβ stimulation, which increases expression of activation marker CD69 and enhances cytokine production (Ciccocioppo et al., 2008; Miscia et al., 2009; Pellicano et al., 2010). This evidence concerns the gene CD69 and Alzheimer disease.